Towards quality assurance and quality control in untargeted metabolomics studies

  • Richard D. Beger
  • , Warwick B. Dunn
  • , Abbas Bandukwala
  • , Bianca Bethan
  • , David Broadhurst
  • , Clary B. Clish
  • , Surendra Dasari
  • , Leslie Derr
  • , Annie Evans
  • , Steve Fischer
  • , Thomas Flynn
  • , Thomas Hartung
  • , David Herrington
  • , Richard Higashi
  • , Ping Ching Hsu
  • , Christina Jones
  • , Maureen Kachman
  • , Helen Karuso
  • , Gary Kruppa
  • , Katrice Lippa
  • Padma Maruvada, Jonathan Mosley, Ioanna Ntai, Claire O’Donovan, Mary Playdon, Daniel Raftery, Daniel Shaughnessy, Amanda Souza, Timothy Spaeder, Barbara Spalholz, Fariba Tayyari, Baljit Ubhi, Mukesh Verma, Tilman Walk, Ian Wilson, Keren Witkin, Daniel W. Bearden, Krista A. Zanetti

Producción científica: Articlerevisión exhaustiva

127 Citas (Scopus)

Resumen

We describe here the agreed upon first development steps and priority objectives of a community engagement effort to address current challenges in quality assurance (QA) and quality control (QC) in untargeted metabolomic studies. This has included (1) a QA and QC questionnaire responded to by the metabolomics community in 2015 which recommended education of the metabolomics community, development of appropriate standard reference materials and providing incentives for laboratories to apply QA and QC; (2) a 2-day ‘Think Tank on Quality Assurance and Quality Control for Untargeted Metabolomic Studies’ held at the National Cancer Institute’s Shady Grove Campus and (3) establishment of the Metabolomics Quality Assurance and Quality Control Consortium (mQACC) to drive forward developments in a coordinated manner.

Idioma originalEnglish
Número de artículo4
PublicaciónMetabolomics
Volumen15
N.º1
DOI
EstadoPublished - ene 1 2019

Nota bibliográfica

Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.

Financiación

FinanciadoresNúmero del financiador
National Institute of Diabetes and Digestive and Kidney DiseasesP30DK017047
National Institute of Diabetes and Digestive and Kidney Diseases

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Biochemistry
    • Clinical Biochemistry

    Huella

    Profundice en los temas de investigación de 'Towards quality assurance and quality control in untargeted metabolomics studies'. En conjunto forman una huella única.

    Citar esto